Stay updated on Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.

Latest updates to the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now includes new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a minor label formatting adjustment (Intervention/Treatment). It also updates recruitment status to indicate no longer looking for participants and updates the revision tag to v3.6.0.SummaryDifference0.4%

- Check18 days agoChange DetectedThe visible Revision tag has changed from v3.5.4 to v3.5.5. This marks an updated page version and does not alter the study details or other user-facing content.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision updated to v3.5.4, replacing the previous v3.5.3. This reflects a new release of the study record interface/content.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page footer revision was updated from v3.5.2 to v3.5.3, indicating a platform release/version change rather than a modification to the underlying clinical trial information.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check97 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.1%

Stay in the know with updates to Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.